Ads by Google
Breast cancer cells grown in 3-D culture can be induced to form normal breast duct-like structures, as opposed to dense cell masses, by activating or inhibiting specific signaling pathways, including antibody binding to the extracellular matrix protein fibronectin.
Resistance to tamoxifen is a common problem in breast cancer treatment, but researchers are identifying the factors that influence sensitivity versus resistance.
Researchers have identified loss of Fiblin-2 as a marker of breast cancer progression since the protein is expressed by normal breast cells but lost in breast cancer cell lines and invasive breast tumors.
The mobile community education and outreach tour, Komen On the Go, will share important information about breast health and breast cancer with all generations.
The Kroger stores is "Giving Hope A Hand" this month during a campaign to raise money for raising awareness of breast cancer.
Researchers at the Massachusetts General Hospital Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors.
Since findings have revealed that some families have increased breast cancer risk, a number of people are turning to cancer genetic services to learn more.
The sharp decline in the rate of new breast cancer cases in 2003 may be related to a national decline in the use of hormone replacement therapy (HRT)
Medical scientists have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment.
The sharp decline in breast cancer in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative.
Members from the laboratory of Stephen Ethier, Ph.D. will present research findings on breast cancer-causing genes and how they operate at the American Association of Cancer Research Annual Meeting.
USA and UK have taken profoundly different approaches in developing genetic testing for breast cancer which has serious implications for users of health care.
Cancer researchers have identified a set of genes they say promote the spread of breast tumors to the lungs.
Discovery could help target drugs for breast cancer to carriers of mutant gene.
Racial differences in the clinical presentation of breast cancer may be due more to biological factors rather than differences in access to healthcare alone.
High risk breast cancer women are recommended to get scans along with Mammograms, not instead of them.
An expert panel by the American Cancer Society has developed new recommendations for the use of magnetic resonance imaging (MRI) for women at increased risk for breast cancer.
Computer-Aided breast cancer detection that uses software designed to improve how radiologists interpret mammograms may instead make readings less accurate.
For the past four years, Susan G. Komen for the Cure have tirelessly advocated for reauthorization of the National Breast and Cervical Cancer Early Detection Program.
MRI scans of women who were diagnosed with cancer in one breast detected over 90 percent of cancers in the other breast that were missed by mammography and clinical breast exam at initial diagnosis.
When added to a medical workup after a breast cancer diagnosis, MRI scans can significantly improve the chances of detecting cancer in the opposite breast,
Women with a recent diagnosis of cancer in one breast should have MRI screening of the opposite breast.
An administrative database that helps appointment secretaries remind women to have mammograms increased the breast cancer screening rate at one large group practice.
"Triple negative" breast cancers, tumors that do not contain any of three significant tumor markers, are aggressive, deadly cancers that affect young, poor minority women, according to a new study.
Surgeon attitudes may contribute to low reconstruction rates of breast cancer patients.
Protein levels in saliva have great potential to assist in the diagnosis, treatment, and follow-up care of breast cancer.
Tykerb, a breast cancer treatment pill from GlaxoSmithKline gets approved by the U.S. Food and Drug Administration.
Enhancing breast cancer awareness, informing women about availability of mammography services and assisting with the coordination of breast cancer treatment services.
To increase awareness and help make a difference in the battle against breast cancer and breast disease, free information sessions are offered to local groups.
Next step will be testing in breast cancer patients.
